Advances in Molecular Classification of AML and MDS and MRD Surveillance for Patients with AML
In order to receive the certificate of participation, you are required to fill out the registration form.
Registration link
Thursday, May 22nd, 2025
12:30 PM (GMT)
04:00 PM (Tehran Time)
Join Zoom Meeting:
https://us06web.zoom.us/j/81785066207
Meeting ID: 817 8506 6207
Passcode: TUMS-2025
Dr. Sanam Loghavi
Associate Professor, Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, USA
Sanam Loghavi is an Associate Professor of Pathology and Laboratory Medicine at the Department of Hematopathology at MD Anderson Cancer Center. She is Board-certified in hematopathology and molecular pathology and specializes in hematologic malignancies, particularly myeloid neoplasms. Her research interests include molecular risk stratification of hematologic neoplasms and measurable residual disease detection. She is the Medical Director of the ECOG/ACRIN Leukemia Bank. She has authored over 240 peer-reviewed publications on hematologic neoplasms and is a co-investigator on several national and internationally run clinical trials for hematologic malignancies. She is the Editor in Chief of the American Society of Hematology (ASH) Image Bank.
Dr. Marjan Yaghmaie
Professor, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Head of Leading House for Iran-North America Academic Partnerships, Tehran University of Medical Sciences, Iran
(Moderator & Facilitator)